Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example ArtifactAssessment: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16

Generated Narrative: ArtifactAssessment

Resource ArtifactAssessment "179698" Version "4" Updated "2023-12-06 08:41:24+0000"

Profile: Adaptation

Artifact Author: Joanne Dehnbostel:

Artifact URL: https://fevir.net/resources/ArtifactAssessment/179698

Artifact Description: This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data.

modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]

identifier: FEvIR Object Identifier/179698

title: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16

artifact: Composition/179466: Recommendation: ADA Obesity Management Recommendation 8.16

content

informationType: container

type: adapted element ()

classifier: string Datatype (Evidence Based Medicine on FHIR Implementation Guide Code System#string-datatype)

path: overallSummary

Components

-InformationTypeSummaryTypeClassifier
*comment8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. AOriginal Resource Content (Evidence Based Medicine on FHIR Implementation Guide Code System#OriginalResourceContent)
*response Rationale for Change to Resource Content (Evidence Based Medicine on FHIR Implementation Guide Code System#RationaleForChange)Suggested change (Evidence Based Medicine on FHIR Implementation Guide Code System#suggested-change)
*change-request8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.Suggested Change to Resource Content (Evidence Based Medicine on FHIR Implementation Guide Code System#SuggestedChange)